7600
Japan Medical Dynamic Marketing,INC.
日本エム・ディ・エム
- Industry
- Precision Instruments
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2022
19,193,098
Mar 2023
21,307,946
Mar 2024
23,177,747
Mar 2025
25,114,033
Mar 2026
23,917,009
Operating profit(thousand JPY)
Mar 2022
2,661,529
Mar 2023
2,024,671
Mar 2024
1,746,914
Mar 2025
1,555,934
Mar 2026
574,185
Operating profit margin(%)
Mar 2022
13.87
Mar 2023
9.5
Mar 2024
7.54
Mar 2025
6.2
Mar 2026
2.4
Profit before tax(thousand JPY)
Mar 2022
2,749,804
Mar 2023
1,769,797
Mar 2024
1,636,787
Mar 2025
-342,399
Mar 2026
493,605
Profit(thousand JPY)
Mar 2022
2,135,693
Mar 2023
1,423,719
Mar 2024
1,271,682
Mar 2025
-461,798
Mar 2026
263,138
Total assets(thousand JPY)
Mar 2022
27,342,722
Mar 2023
29,434,714
Mar 2024
31,485,859
Mar 2025
33,667,198
Mar 2026
35,678,999
Cash and cash equivalents(thousand JPY)
Mar 2022
2,590,849
Mar 2023
2,804,928
Mar 2024
2,321,552
Mar 2025
3,182,342
Mar 2026
3,107,052
Cash flows from operating activities(thousand JPY)
Mar 2022
3,111,665
Mar 2023
2,186,226
Mar 2024
2,104,913
Mar 2025
1,046,627
Mar 2026
205,554
Cash flows from investing activities(thousand JPY)
Mar 2022
-1,750,123
Mar 2023
-1,481,919
Mar 2024
-1,804,728
Mar 2025
-1,666,919
Mar 2026
-1,995,847
Cash flows from financing activities(thousand JPY)
Mar 2022
-1,287,745
Mar 2023
-514,780
Mar 2024
-840,710
Mar 2025
1,490,168
Mar 2026
1,648,594
Return on equity(%)
Mar 2022
10.7
Mar 2023
6.4
Mar 2024
5.2
Mar 2025
-1.8
Mar 2026
1.1
Equity ratio(%)
Mar 2022
78.2
Mar 2023
78.7
Mar 2024
81
Mar 2025
73.3
Mar 2026
71.2
Earnings per share(JPY per share)
Mar 2022
80.95
Mar 2023
54.03
Mar 2024
48.31
Mar 2025
-17.54
Mar 2026
9.99
Net assets per share(JPY per share)
Mar 2022
810.59
Mar 2023
880.64
Mar 2024
968.74
Mar 2025
937.15
Mar 2026
963.82
Dividend per share(JPY per share)
Mar 2022
12
Mar 2023
13
Mar 2024
14
Mar 2025
15
Mar 2026
17
Payout ratio(%)
Mar 2022
14.82
Mar 2023
24.06
Mar 2024
28.98
Mar 2025
-
Mar 2026
170.17
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.